Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

[89Zr]Df-IAB22M2C Anti-CD8 Minibody PET/CT Imaging to Assess the in Vivo Distribution of CD8+ T-cells in COVID-19 Patients

NCT04874818 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT04874818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04874818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
[89Zr]Df-IAB22M2C Anti-CD8 Minibody PET/CT Imaging to Assess the in Vivo Distribution of CD8+ T-cells in COVID-19 Patients
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Terminated
Start date
February 14, 2022
Completion date
December 31, 2022
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphopenia due to covid-19, pet imaging, t-cell